About dariohealth - DRIO
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
DRIO At a Glance
DarioHealth Corp.
322 West 57th Street
New York, New York 10019
| Phone | 1-833-914-3796 | Revenue | 22.36M | |
| Industry | Medical Specialties | Net Income | -20,288,330.00 | |
| Sector | Health Technology | Employees | 165 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
DRIO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.027 |
| Price to Book Ratio | 1.157 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.536 |
| Enterprise Value to Sales | 2.273 |
| Total Debt to Enterprise Value | 0.625 |
DRIO Efficiency
| Revenue/Employee | 135,509.091 |
| Income Per Employee | -122,959.576 |
| Receivables Turnover | 8.371 |
| Total Asset Turnover | 0.195 |
DRIO Liquidity
| Current Ratio | 3.734 |
| Quick Ratio | 3.271 |
| Cash Ratio | 2.815 |
DRIO Profitability
| Gross Margin | 56.644 |
| Operating Margin | -163.938 |
| Pretax Margin | -186.095 |
| Net Margin | -90.739 |
| Return on Assets | -17.722 |
| Return on Equity | -28.996 |
| Return on Total Capital | -20.356 |
| Return on Invested Capital | -20.756 |
DRIO Capital Structure
| Total Debt to Total Equity | 46.742 |
| Total Debt to Total Capital | 31.853 |
| Total Debt to Total Assets | 28.842 |
| Long-Term Debt to Equity | 46.109 |
| Long-Term Debt to Total Capital | 31.422 |